IMAgine an Experienced, Patient-Centric Team
IMA Clinical Research is clinically founded and clinically run by people who share a passion for helping others. Supported by unparalleled intellectual horsepower and highly dedicated executives, we drive clarity in complex situations and accelerate the development of novel treatments.
Meet Our Leaders
Our world-class research team comprises principal investigators and licensed healthcare professionals with a wealth of experience in the industry.
David C. Pulver, MD, CEO and Founder of The IMA Group, is certified by the American Board of Internal Medicine and American Board of Addiction Medicine and serves as Clinical Assistant Professor of Medicine at New York Medical College. Since founding IMA thirty years ago, Dr. Pulver has overseen the growth of the company from a single office to a network of more than ninety offices in twenty states and the District of Columbia. He received his MD degree from New York Medical College in 1975.
David C. Pulver, MD
CEO and Founder, The IMA Group
Mark I. Weinberger, PhD, MPH, President of The IMA Group, is a licensed psychologist and psychiatric epidemiologist who joined IMA in 2011. Dr. Weinberger received his PhD in clinical psychology from the University of Massachusetts Amherst and his MPH in epidemiology from New York Medical College. In 2018, Dr. Weinberger completed a Graduate Professional Certificate in Principles of Finance from Harvard’s Extension School. He serves as Clinical Instructor of Psychology in Psychiatry at Weill Cornell Medical College, and he’s responsible for the daily operations of the company.
Mark I. Weinberger, PhD, MPH
President, The IMA Group
Dr. Rocci is a seasoned pharmaceutical scientist and executive with over thirty-five years of business leadership experience, thirty of which have been spent in the Pharmaceutical Services industry. He currently serves as an Executive Advisor to IMA Clinical Research and as Chairman of Solvias AG. Previous executive roles include President of ICON Development Solutions and Chief Executive Officer of Prevalere Life Sciences, Inc. Dr. Rocci began his professional career with academic appointments at the Philadelphia College of Pharmacy and Science and the Division of Clinical Pharmacology in the Department of Medicine at Jefferson Medical College. Dr. Rocci has extensive advisory and board level experience in the pharmaceutical services sector.
Mario Rocci, PhD, FCP, FFIP
Bringing over forty years of clinical research experience with pharmaceutical companies, service providers and research sites, Mike joined IMA in 2021. He has held roles in operations, strategic planning and proposals, observational research and project directing. His tenure was spent with numerous leading organizations, including Bioclinica, ICON, Ayerst Laboratories and Pfizer. Mike’s broad therapeutic experience across Phase I-IV trials and operational delivery expertise in interventional, pragmatic and observational research models will further IMA’s expertise.
Executive Vice President, Clinical Research
With over twenty-five years of experience in clinical research and healthcare services, Deb joined IMA in 2021. Her career began in establishing new business infrastructure and sales growth of a site management organization and patient recruitment company. Prior to joining IMA, Deb held numerous executive level positions with ICON Clinical Research and Optum/Quality Metric. This experience provides a broad view across all research stakeholders. Deb brings extensive experience in developing strategic relationships and complex solutions, as well as in sales leadership and marketing.
Senior Vice President, Commercial Affairs, Clinical Research
Jamie joined IMA Clinical Research in 2021, bringing more than twenty-five years of medical and clinical research experience. He combined his passion for medicine and research as a study coordinator at Eastern Virginia Medical School where he oversaw a multitude of Phase II-III studies in diabetes. Jamie has held various positions of increasing responsibility in both pharma and CROs as a data analyst, clinical research monitor, project manager, program director, strategic account director and head of operational delivery. His most recent roles at CROs involved executive oversight of large portfolios of clinical research programs and several years managing real-world evidence programs. He brings significant experience in organizational growth and development, operational management and business development.
Jamie Schimmel, MPA
Vice President, Clinical Research Operations
Jelena Kunovac, M.D., M.S., joined IMA in 2019 as Chief Scientific Officer. With more than twenty-five years of experience in the clinical research industry, she founded three research centers and conducted more than 450 clinical trials. Board-Certified in Psychiatry, she completed her Residency Training at the University of California, San Diego after having earned her master’s degree in Biological Psychiatry and an M.D. from the University of Belgrade School of Medicine where she graduated as the Valedictorian of her class. In addition, Dr. Kunovac is an Adjunct Assistant Professor of Psychiatry at the University of Nevada, Las Vegas. She regularly authors scientific publications in respected medical journals and presents her research at scientific meetings around the world.
Jelena Kunovac, MD, MS
Chief Scientific Officer
James Greenwald, M.D., Ph.D., joined IMA Clinical Research in 2018. He is the Medical Director of Clinical Research at the New York, Chicago and St. Louis sites. He received his M.D. and Ph.D. from the Ohio State University in Columbus, Ohio. He completed his residency training in Internal Medicine at the Johns Hopkins Hospital in Baltimore, Maryland and became a faculty member at the Washington University School of Medicine. He’s been a clinical research investigator since 2003. Prior to joining IMA, Dr. Greenwald was the President and Medical Director of Medex Healthcare Research, Inc.
James Greenwald, MD, PhD